Skip to content

Author

Luis Antonio Díaz

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Review Article: Fibrosis-4 Index in Steatotic Liver Disease-Past, Present and Future.

BACKGROUND Steatotic liver disease (SLD) is highly prevalent, and fibrosis stage is the strongest determinant of liver-related outcomes, hepatocellular carcinoma and mortality. Liver biopsy remains the reference standard for staging, but it is invasive, subject to sampling and observer variability. These limitations ha...

K. Soni, V. Jahagirdar, Omar Albhaisi et al. · 0 citations
Sep 2026

Risk Factors and Definition of Younger-Onset Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Cirrhosis.

BACKGROUND & AIMS Cirrhosis from metabolic dysfunction-associated steatotic liver disease (MASLD) usually develops with advancing age, yet a subset of patients presents at younger ages. We examined genetic and metabolic factors associated with younger-onset MASLD cirrhosis. APPROACH AND RESULTS Adults with biopsy-pro...

Veeral H. Ajmera, Linus Schwantes-An, Luis Antonio Díaz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.